Skip to main content

Table 1 Patient profile

From: Impact of serum potassium on therapeutic prognosis of maintenance hemodialysis patients on angiotensin receptor antagonists

   

ARB

 
  

Total

(+)

(–)

p value

Age

(Years old)

68.8 ± 6.33

68.1 ± 6.10

70.1 ± 6.71

0.234

Gender (M to F ratio)

 

149:111

95:72

54:39

0.855

Vintage of dialysis

(Years)

5.61 ± 3.25

5.63 ± 3.30

5.56 ± 3.18

0.939

Diabetes

 

89

63

26

0.112

CAD

 

50

37

13

0.109

CHF

 

30

18

12

0.609

Stroke

 

21

13

8

0.817

SBP at the beginning of session

(mmHg)

148.5 ± 9.40

153.2 ± 7.99

140.1 ± 10.3

<0.001

DBP at the beginning of session

(mmHg)

74.5 ± 5.44

75.6 ± 5.16

72.4 ± 5.81

0.024

BUN

(mg/dL)

63.0 ± 5.25

63.4 ± 5.16

62.5 ± 5.42

0.503

Kt/V

 

0.96 ± 0.12

0.96 ± 0.11

0.96 ± 0.11

0.997

Alb

(g/dL)

3.63 ± 0.19

3.65 ± 0.17

3.60 ± 0.21

0.354

Hb

(g/dL)

10.0 ± 0.33

10.0 ± 0.32

10.1 ± 0.35

0.570

CRP

(mg/dL)

1.00 ± 0.99

0.97 ± 1.10

1.07 ± 0.77

0.701

K

(mEq/L)

5.0 ± 0.3

5.0 ± 0.3

4.9 ± 0.3

0.053

Ca

(mg/dL)

8.6 ± 0.3

8.6 ± 0.3

8.5 ± 0.3

0.096

P

(mg/dL)

5.3 ± 0.4

5.3 ± 0.4

5.3 ± 0.5

0.928

TC

(mg/dL)

155.4 ± 18.4

154.8 ± 18.0

156.3 ± 19.1

0.769

Blood glucose

(mg/dL)

123.4 ± 19.9

122.4 ± 19.5

125.3 ± 20.9

0.576

AF

 

21

10

11

0.098

Changes of ST–T segment in ECG

 

101

71

30

0.105

HCV infection

 

18

10

8

0.428

ACEI

 

20

12

8

0.683

ARB

 

167

167

0

CCB

 

186

139

47

<0.001

beta-B

 

88

66

22

0.009

VD

 

157

111

46

0.007

Weekly dose of Erythropoietin/DW

(U/w/kg)

119.7 ± 44.4

121.5 ± 44.5

116.6 ± 44.6

0.354

  1. CAD coronary artery disease, CHF congestive heart failure, SBP systolic blood pressure, DBP diastolic blood pressure, BUN blood urea nitrogen, Alb albumin, Hb hemoglobin, CRP C-reactive protein, K serum potassium, Ca calcium, P phosphorus, TC total cholesterol, AF atrial fibrillation, HCV hepatitis C virus, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker, CCB calcium channel blocker, beta-B beta receptor blocker, VD vitamin D3, DW dry weight